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ABSTRACT
Even though nearly every human gene has at least
one alternative splice form, very little is so far known
about the structure and function of resulting protein
products. It is becoming increasingly clear that a
significant fraction of all isoforms are products of
noisy selection of splice sites and thus contribute
little to actual functional diversity, and may poten-
tially be deleterious. In this study, we examine the
impact of alternative splicing on protein sequence
and structure in three datasets: alternative splicing
events conserved across multiple species, alterna-
tive splicing events in genes that are strongly linked
to disease and all observed alternative splicing
events. We find that the vast majority of all alterna-
tive isoforms result in unstable protein conforma-
tions. In contrast to that, the small subset of
isoforms conserved across species tends to main-
tain protein structural integrity to a greater extent.
Alternative splicing in disease-associated genes
produces unstable structures just as frequently as
all other genes, indicating that selection to reduce
the effects of alternative splicing on this set is not
especially pronounced. Overall, the properties of
alternative spliced proteins are consistent with the
outcome of noisy selection of splice sites by splic-
ing machinery.
INTRODUCTION
Bioinformatic analysis of expressed sequence tag (EST)
sequences as well as microarray experiments shows that
at least 78% of all human genes undergo alternative splic-
ing, producing an average of four isoforms for every gene
(1–4). Three broad hypotheses have been proposed to
explain the prevalence of alternative splicing in higher
Eukaryotes. The ﬁrst hypothesis is that alternative splicing
generates functional diversity by producing alternative
protein products (5–7). The second is that alternative
splicing acts as a regulation mechanism to control the
level of useful gene products, by means of changing the
fraction of functional and non-functional transcripts (8–
10). The third hypothesis is that alternative transcripts are
non functional, partly as a result of stochastic noise in the
splicing machinery (2,6).
There are many well-established examples of alternative
splicing with diverse functional consequences at the pro-
tein level, supporting the ﬁrst hypothesis. Almost all types
of molecular functions have been reported, including
antagonists to the action of a major isoform (11), modiﬁed
ligand-binding speciﬁcity (12), altered subcellular location
(13) and reduced protein halﬂife (14).
There are also examples in support of the second
hypothesis, alternative splicing that is functional at the
message level, and acting as a mechanism for switching
oﬀ or downregulating the expression of a protein (9).
Some well-established examples are Drosophila sex-lethal
(Sxl) (15), mdm2 (16), ABCC4 (17), MID1 (18), hUPF2
(19). Regulation via nonsense-mediated decay (NMD) has
also been suggested, although a recent microarray based
survey by Pan et al. indicates that only a small fraction of
premature stop codon transcripts are substantially regu-
lated in this way (20). Nevertheless, it remains the case
that the vast majority of alternative transcripts have no
known function at any level, leaving the possibility that
the third hypothesis, most splicing is in some sense non-
functional noise, is the predominant explanation.
The extent to which the non-functional noise is a
contributing factor to the protein diversity remains largely
unexplored. Although there have been numerous bioinfor-
matics studies that have looked at the impact of alterna-
tive splicing on proteins, none have been focused explicitly
on testing noise hypothesis (21–27). Furthermore, due
to diﬀerences in methodology it is hard to reconcile
conclusions reached by various studies. While there is
evidence, which shows that disruption of protein domains
is less frequent than expected by chance (24), and that
there is a greater tendency to conserve reading frames,
there is also clear evidence that very few alternative
events are conserved across species and that a large frac-
tion of resulting proteins are unstable (26) or need to
undergo large conformational changes to assume stable
folds (28).
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non-trivial properties of the distributions of isoform abun-
dance and diversity are consistent with most alternative
splicing being the consequence of noise in the splicing pro-
cess (29). In this study, we test this hypothesis on the pro-
tein level. Using random exon deletions as a control, we
examine the eﬀect of observed deletions on structural
properties such as exposed hydrophobic area, loss of 3D
contacts and length of the gap created in the polypeptide
chain. Splicing in monogenic disease genes is also investi-
gated, since these are likely to be under the strongest selec-
tion pressure to maintain function.
We ﬁnd that, on average, alternative splicing events
have a markedly deleterious eﬀect on protein domain
structure, similar to that found for random exon deletions,
and so are unlikely to encode for alternative protein func-
tion. Disease-associated genes do not show special sensi-
tivity to alternative splicing, indicating that there is no
strong selection to remove deleterious changes introduced
by alternative splicing. Overall, our conclusion is that the
majority of alternative proteins are structurally unstable
and if expressed will be without function, consistent with
the noisy splicing hypothesis.
MATERIALS AND METHODS
Data sources
The human genome sequence (30) was downloaded from
NCBI (NCBI Human Genome Build 35). The transcript
data were obtained from Refseq (31) (Release 17; May
2006; 29475 sequences), Unigene (31) (May 2006;
6586000 sequences) and H-InvDB (41) (Release
3.0;449186 sequences). The location of genes on chromo-
somes was taken from Refseq database annotation.
Information about homologous genes in other species
was obtained from the NCBI Homologene Database
(31) (Release 48; May 2006). For each gene, all sequences
were aligned to a human genomic contig using the sim4
algorithm (32) and then checked for alignment errors (see
list of rules below).
Alignment quality control
The following ﬁve rules are used to identify and reject
sequences containing alignment and sequencing errors.
(i) All implied splice sites must conform to the spliceo-
some pattern—‘GT/AG’.
(ii) All exons must have >90% identity with the corre-
sponding genomic sequence.
(iii) Alignment to genomic sequence must not contain
any missing segments.
(iv) The sequence around exon junctions (six nucleotides
into each exon) must have 100% identity with the
corresponding contig.
(v) The cDNA must not contain any introns of size
<30 nucleotides.
Two additional ﬁlters were applied to minor isoforms:
(a) Minor isoforms must share at least one exon with the
corresponding major isoform (overlap of >1 nucleotide).
(b) Minor isoforms must not contain an intron retention
event relative to the major isoform.
Selection of major isoforms
For each gene, we identiﬁed one of the cDNAs as the
major isoform. We ﬁrst created a list of introns and all
sequences that are associated with those introns. For each
intron, we calculate the number of EST sequences and the
number of unique EST libraries that contain the resulting
exon–exon bridge. We then use these data with the rules
below to choose a major isoform.
(i) mRNA-only Rule: only full-length mRNAs are
selected.
(ii) Pairwise Library Rule: if there is more than one
full-length isoform, each candidate isoform is com-
pared with all others candidates. In each compari-
son, for each exon–exon bridge a score of 1 is
assigned to the isoform with the greater number
of EST libraries with at least one occurrence of
that bridge. Isoforms are then sorted by total
score, larger scores ranking higher.
(iii) Lowest Number of Libraries Rule: if application
of rule (ii) results in two or more isoforms with the
same score, isoforms are further ranked on the basis
of the least supported exon–exon bridge in each. For
each exon–exon bridge in an isoform, the number of
EST libraries containing at least one sequence with
that bridge is determined. The smallest number of
libraries supporting any of the bridges is noted, and
isoforms are ranked by these values.
(iv) Lowest Number of EST Observations Rule: if appli-
cation of rule (iii) results in two or more isoforms
with the same rank, the procedure of rule (iii) is
repeated, now ranking based on the minimal
number of ESTs supporting a bridge in each iso-
form, rather than the minimal number of libraries
(v) Longest Isoform Rule: if application of rule (iv) still
results in two or more isoforms with the same rank,
the longest isoform is chosen.
Length bias primarily arises from rule (v), simply choos-
ing the longest isoform. But this rule is only applied in
cases where the ﬁrst four do not result in a clear choice, a
relatively rare event. If this rule is omitted, arbitrarily
selecting from the same ranked isoforms after application
of rule (iv), the same isoform is selected in 88% of cases.
Application of rule (ii) may also be somewhat biased
since in comparing two isoforms, a score is given for
every pair of introns, and longer isoforms tend to have
more introns. If both rule (v) and rule (ii) are dropped,
the same isoform is selected for 75% of genes. Note that
the drop from 88% to 75% greatly exaggerates the length
bias of rule (ii), since in most cases selection is based on
the library count criterion, independent of length.
Reconstruction of exon structure for EST sequences
The full exon structure of EST-derived isoforms must be
predicted before these isoforms can be translated. We
make the assumption that missing exon structure is iden-
tical to the exon structure observed in the mRNA
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isoforms are used as templates to expand each EST to a
full-length transcript. For 30 EST sequences, we copy exon
structure starting at the 50 end of the major isoform until
we ﬁnd an overlap with an exon in the EST sequence.
Since EST sequences typically end at an arbitrary location
within an exon, the overlapping exon is discarded and
replaced with the corresponding exon from the major iso-
form. An equivalent process is used to extend 50 EST
sequences. For internal EST sequences, the exon structure
is copied from both ends of the major isoform.
Location of translation initiation site
Although typically the ﬁrst ‘AUG’ in an mRNA sequence
is used to initiate translation, this is not always correct
(33), and the exact location of protein translation initia-
tion is generally not known. To make sure that our protein
translations are plausible, we ﬁnd the longest translation
with the translation initiation site supported by other spe-
cies. This is done by ﬁrst ﬁnding all possible translations
of an isoform. The translations are sorted according to
distance to the 50 end of the transcript, and the ﬁrst 20
amino acids of each implied translation are searched
against a database of all N-terminal 20 amino-acid
sequences compiled from 40 Eukaryotic Refseq genomes
(540000 sequences). The translation initiation sites are
sorted based on the number of hits to other species, and
the one with the most hits is selected.
Approximately 55% of all isoforms had translations
that could be conﬁrmed in more than two species, the
remaining 45% were found only in human. As a check
of this procedure, we compared our translations of
Refseq sequences with Refseq annotated translations
and found 95% agreement between the two sets. In
some cases a single mRNA transcript can produce a vari-
ety of protein sequences through leaky translation (34). In
our analysis, we assume that each isoform produces a
single protein sequence.
Protein splicing fragments
Protein translations of isoforms were aligned using the
genomic coordinates of the underlying exons. This is
done by ﬁrst generating an mRNA alignment between
major and minor isoforms pairs to genomic sequence,
and then using the mRNA alignment to generate protein
alignment. Protein splicing fragments (PSFs) are deﬁned
as regions within the protein alignment that diﬀer. The
alternative splicing event(s) that are responsible for produ-
cing diﬀerences in protein sequence are identiﬁed by look-
ing for alternative introns in the region underlying each
PSF (Figure 1).
Conservation of splice junctions
We search a 40-nucleotide sequence around each splice
junction (20 into each exon) against all EST and mRNA
sequences of all homologous genes from other species.
Gene homology information was obtained from the
NBCI Homologene Database (31). Transcripts of homol-
ogous genes were obtained from the Unigene database. All
40 nucleotides must align with a minimum E-score of 0.01
and no more than two gaps to the corresponding fragment
in the homologous transcript. We deﬁne the conservation
score for each junction as the number of other species that
had at least one signiﬁcant hit to that junction. For exam-
ple, if a junction was detected in mouse, rat and human, it
would receive a conservation score of 3. This procedure
was repeated for all exon–exon junctions from all isoforms
in all genes.
Conservation score for PSFs
Using the mapping between exon structure and protein
translation, we ﬁnd the subset of introns in the major
and minor isoforms underlying each PSF. By comparing
genomic coordinates of minor and major introns within
each PSF’s intron subset, we identify all alternative intron
pairs responsible for production of the PSF. The conser-
vation score for a PSF is taken to be the maximum species
conservation score of all the minor isoform introns. For
example, if an exon insertion event resulted in an Insertion
PSF with two alternative splice junctions and the ﬁrst
junction is supported by two species while the second
one is supported by three, the conservation score is 3.
Mapping of PSFs to structure
A PSI-BLAST (35) position speciﬁc matrix (PSSM) is
complied for the protein sequence of each major isoform,
by searching against the Uniprot (36) database for three
Figure 1. Identiﬁcation of PSFs. Protein sequences corresponding to the major and a minor isoform of a gene are aligned, and regions in the
alignment that diﬀer identiﬁed. Deletions are deﬁned as missing fragments in minor isoforms. Replacement is deﬁned as a substitution of identical
size. Truncations and elongations are substitutions that change the length of a fragment. Numbers above each intron bridge are conservation scores,
the number of species in which this or a homologous bridge is found. Here, the alternative intron has a score of 2, indicating it was detected in
human and one other species (the maximum possible conservation score is 11).
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(37) protein sequence database for potential homologous
templates using PSI-BLAST with an E-score cutoﬀ of
10e-5. The location of each exon in the 3D structure is
obtained by mapping the protein segment corresponding
to the exon onto the alignment. The PSF coverage score
was calculated as the fraction of all residues in the PSF
that are covered by a structural template. Only PSFs that
are 95% covered by a structural template were used in
this study.
Calculation of structural properties
We deleted the atomic coordinates of protein fragments
corresponding to deletion PSFs from the structural tem-
plates and calculated various statistics. CCP4 (38) was
used to calculate the exposed surface area of all atoms
in the original templates and for all atoms in the modiﬁed
templates formed by deletion of PSFs. The newly exposed
area is calculated as the sum over all atoms that were
previously buried but now exposed (buried deﬁned as
zero surface area). The newly exposed hydrophobic area
is the sum of all contributions from carbon atoms to newly
exposed area. The number of lost contacts is the number
of contacts in an original template that no longer exist in
the modiﬁed template (contact deﬁned as distance between
atoms of less than 6A ˚ ). Deletion end-to-end distance was
calculated as the distance between Ca atoms of residues at
each end of a deletion.
RESULTS
Difference in protein sequences of isoforms
We ﬁrst examine the eﬀect of alternative splicing at the
protein sequence level. We compiled an initial set of 85136
isoforms from 19743 genes using sequence data obtained
from the Refseq (39), Unigene (40) and Hinv (41) data-
bases. All isoforms in this set were subjected to quality
control checks to ensure that each splice junction is
valid. An additional 18995 isoforms were removed
because of uncertainty in the alignment at the 50 or 30
ends. Transcripts from genes with no observed alternative
isoforms were also eliminated, leaving 10972 genes with
two or more isoforms each. There were a total of 55217
isoforms, of which 40% (20998) were derived from full-
length mRNAs, and the remaining 60% (34219) were
derived from EST sequences. Partial isoforms derived
from ESTs were completed by copying missing exon struc-
ture from the corresponding major isoform (see ‘Methods’
section for details of all these procedures).
All validated isoforms were translated to provide the
corresponding protein sequences, allowing for possible
errors in N-terminal position. For each gene, one isoform
was selected as the major isoform, using the procedure
described in ‘Methods’ section. Note that while the
choice of major isoform is occasionally ambiguous, for
the vast majority of cases, it is straightforward. To
obtain an overall measure of protein sequence length dif-
ferences between minor and major isoforms, we sub-
tracted the length of the major isoform from that of
each minor isoform of the same gene and plotted the
histogram of length diﬀerences (Figure 2). Approximately
20% of all minor isoforms had the same protein sequence
length as the major isoform, mostly due to alternative
splicing outside the coding regions (not shown in the
plot). Most minor isoforms are signiﬁcantly shorter than
major isoforms ( 70%) and only 9% of all minor iso-
forms are longer than major isoforms. Care was taken
to minimize any bias towards selecting longer isoforms
as the major ones, so that this eﬀect is not an artifact.
The signal is dominated by protein length diﬀerences of
more than 100 amino acids ( 43%).
We repeated this analysis on the subset of isoforms
derived only from full-length mRNAs. We found that
both datasets have approximately the same distribution
of length diﬀerences. The full-length mRNA dataset has
an increased fraction of longer minor isoforms ( 17%
rather than  9%) and a correspondingly smaller fraction
of same length isoforms, but the fraction of shorter major
isoforms remains the same in both sets. Thus the shortness
of the minor isoforms is not an artifact of incorrect recon-
struction from ESTs. Total 10160 isoforms are predicted
to be subject to the NMD degradation pathway (predic-
tion based on the ‘50 nucleotide rule’) (8). Removal of
these results in a reduction in the fraction of isoforms
more than 100 amino acids shorter than the major one
(43–36%). The same eﬀect is observed in the full-length
mRNA-only subset.
In order to analyze the diﬀerences between isoforms
further, we aligned the implied protein translation of
each minor isoform to that of the corresponding major
isoform. The alignment is preformed in two steps. First,
we align the major and minor isoforms’ exons to a
common genome reference frame. Second, we use the
resulting mRNA alignment to create aligned protein
translations. Figure 1 illustrates the procedure.
We term each continuous stretch of diﬀerence within an
alignment between two isoforms a PSF. On the one hand,
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Figure 2. Distribution of diﬀerences in amino-acid sequence length.
Distribution of diﬀerences in amino-acid sequence length between pro-
teins coded for by major and minor isoforms. Most minor isoforms are
substantially shorter than the major isoforms.
Nucleic Acids Research, 2009,Vol.37, No. 14 4865in cases where alternative splicing lies outside the coding
region, the protein alignment will be identical and thus no
PSF will be produced. On the other hand, if there are
multiple alternative splicing events within a coding
region, multiple PSFs will be generated from a single
major/minor comparison. For example, in the tropomyo-
sin 2 (TPM2) gene (Figure 3), there are two alternative
splicing diﬀerences between the major and minor iso-
forms, generating two PSFs.
The PSFs were classiﬁed into three broad categories:
deletion, insertion and substitution. Substitutions were
further classiﬁed into three classes: perfect replacement—
a fragment is replaced with another fragment of the same
size; truncation—a fragment is replaced with a smaller
fragment; and elongation—a fragment is replaced with a
larger fragment. We also classiﬁed PSFs into four broad
classes based on location: N-terminal, internal, C-terminal
and not classiﬁed. The last category is reserved for diﬀer-
ences that extend over the entire length of the alignment.
As an example, consider the alignment between two
isoforms of TPM2 gene in Figure 3, where thereare two
replacements, one creating an internal 26 residue long
substitution, the other also a 26 residue replacement, at
the C terminus.
The results of the PSF classiﬁcation are summarized in
Table 1. As already implied by the whole protein length
comparisons, the majority of fragments are deletions and
truncations (87.6% of all fragments). Many of the C-term-
inal truncations are produced as a result of premature stop
codons due to frame shifts. Many of these are predicted to
be degraded by NMD by the ‘50 nucleotide rule’ (8,42),
although this prediction might not be correct: as noted
earlier, recent data from Pan et al., suggest that a
signiﬁcant fraction of transcripts with premature stop
codons will not be aﬀected by NMD (20). The most
common types of deletions are N-terminal deletions.
These are largely generated through alternative pro-
moters, and strictly speaking, should be considered sepa-
rately from other alternative splicing events, since diﬀerent
machinery is involved. As far as is known, there is no
quality control mechanism similar to NMD for deletions
on the N-terminal ends of proteins, thus we would expect
that these proteins are actually produced. Replacement of
a protein fragment with another protein fragment of
exactly the same size is the least common type of fragment
(0.4%). Although rare, these events are highly expressed
(supported by large numbers of EST observations) and we
will show in the next section that these events exhibit the
strongest conservation signal across multiple species.
Figure 3. Example of PSFs in TPM2. The exon alignment of two isoforms shows two PSFs. In this case, both are the result of exon swaps (an exon
in one isoform is replaced by a diﬀerent one in the other isoform), and in each instance, the replacement exon is the same length as the major isoform
one. The PSF in the middle of the sequence is thus classiﬁed as an internal replacement, and the one at the 30 end is a C-terminal replacement.
Table 1. Classiﬁcation of PSFs
Not classiﬁed Cterm Internal Nterm Fraction (%)
Truncation 3000 9425 1252 2336 47.2
Deletion 0 278 4603 8359 39
Elongation 369 1070 507 537 7.3
Insertion 0 25 1597 444 6.1
Replacement 1 39 68 35 0.4
Fraction (%) 9.9 31.9 23.6 34.5 100
Subsequences aﬀected by splicing are classiﬁed by the eﬀect on length
(truncation—a shorter fragment than in the major isoform, deletion—
removal of a fragment, elongation—a longer fragment than in the
major isoform, insertion—insertion of a fragment and replacement—
replacement of a fragment with another of the same length) and by
location in the open reading frame (not classiﬁed, C terminal, internal
and N terminal). The majority of PSFs belong to the deletion and
truncation categories.
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To obtain a splicing subset enriched for function, we com-
piled a list of alternative splicing events conserved across
multiple species. Although it is reasonable to assume that
cross-species conservation is correlated to functionality,
there are two caveats to be borne in mind. First, the con-
served subset is biased towards genes expressed in high
abundance in other species, since they are more likely to
be detected in EST experiments. Second, high abundance
genes are also likely to produce more alternative isoforms
as a result of noise (29), so some of the isoforms are likely
to be non-functional. Nevertheless, as noted earlier, sev-
eral evolutionary trends have been shown to be correlated
to conservation of alternative splicing events.
To ﬁnd conserved alternative splicing events, we
searched sequences of all exon–exon junctions for signiﬁ-
cant hits in transcripts of homologous genes in other spe-
cies (obtained from Homologene, see ‘Methods’ section),
and deﬁned the conservation score for each junction as the
number of species that had at least one signiﬁcant hit to
that junction. We then deﬁned the conservation score for
each PSF as the maximum conservation score from all of
alternative splice junctions that underlie that PSF. The
distribution of PSF conservation scores from all isoforms
except those predicted to be subject to NMD is shown in
Table 2.
Alternative splicing where a protein fragment is
replaced by another of the same length shows strongest
conservation. These represent 9.8% of all PSFs conserved
across four or more species—a 25-fold increase from the
0.4% value in the human-only subset. The fraction of
insertions and elongations also increases with increasing
conservation, while deletions and truncations decrease.
The most obvious explanation for these observations is
that deletions and truncations have a greater tendency to
disrupt protein structure and are thus less likely to be
conserved. As we observed in the distribution of length
changes (Figure 2), deletions and truncations tend to
remove a large numbers of residues, typically more than
a 100. Of course, perfect replacements are least likely to
aﬀect protein structure, since they preserve protein length.
Insertions and elongations tend to change the length by
fewer than 25 residues, and are thus also less likely to
disrupt structure. This eﬀect is investigated further in the
next section.
The relationship between change in length and conser-
vation across species is shown in Figure 4A. Figure 4B
shows the relationship between length change and minor
isoform abundance. The assumption here is that more
abundant isoforms are more likely to be functional, pro-
viding another means of examining the relationship
between structure properties and function. Abundance is
deﬁned as the number of EST observations for alternative
splice junctions underlying the PSF. In cases where there
are multiple alternative splice junctions underlying a PSF,
we use the junction with the highest EST count as the
measure of abundance. This is an approximation since it
does not take into account EST sampling biases, but it is
expected to be correlated to the actual number of copies of
the isoform in the sample. Figure 4 clearly shows that
change in length is highly correlated to both abundance
and conservation across species. Small changes are both
conserved and abundant, suggesting that they are more
likely to be functional.
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Figure 4. Cross-species conservation and abundance versus PSFs length change. PSFs were divided into 120 groups, with at least 200 PSFs within
each group, and mean cross-species conservation scores and abundance were calculated. Large changes in length are typically only found in
unconserved splice forms and at low abundance.
Table 2. Cross-species conservation of PSFs
Human
only
Two
species
Three
species
More than
four species
Replacement 0.4 0.6 6.2 9.8
Deletion 50.6 38.7 27.6 29.4
Truncation 34.2 29.6 29.2 21.6
Elongation 7.7 15.7 26.9 33.3
Insertion 7 15.4 10 5.9
Total (%) 100 100 100 100
N (PSFs) 23287 1761 438 51
Splicing eﬀects most likely to be functional (replacement, and
elongation and insertion) are markedly enhanced in the conserved sets.
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We have also analyzed the frequency of alternative spli-
cing events in a subset of genes strongly associated with
human diseases. Disease-associated genes were obtained
from three databases: OMIM (43) (2241 genes), HGMD
(44) (834 genes) and Genetests (45) (1000 genes). We also
compiled a CORE set of 530 genes found in all three
databases. Although the exact mechanism leading to dis-
ease is diﬀerent in each case, in general, the cause can be
attributed to reduced total activity of a protein product as
a result of a mutation of some kind.
The extent of change to protein sequence as a result of
alternative splicing is far greater than the change due to a
typical single amino acid mutation, and as a consequence
the likelihood of disruption of function is also greater. But
unlike a deleterious amino acid mutation, which will aﬀect
all transcripts of a gene, alternative splicing only aﬀects a
fraction of all transcripts. As long as the fraction of alter-
native transcripts does not exceed some level where the
normal function of a gene is seriously aﬀected there will
be no pressure to reduce deleterious changes. If these
assumptions are correct, disease genes should undergo
alternative splicing with the same frequency as all other
genes.
Figure 5 shows the distribution of the number of iso-
forms per gene for all human genes in our database (19743
genes, 85136 isoforms) and for the various subsets of
disease-associated ones. Except for the ﬁrst set of bars
(single isoform, i.e. no alternative spicing), all the
sets show nearly identical distributions. Abundance of
alternative isoforms (as measured by fraction of all tran-
scripts per gene that are alternative) is nearly identical
(8% all vs  7% disease). We also looked at the distribu-
tion of overall length change between major and minor
forms of proteins in disease-associated genes, which also
shows no signiﬁcant diﬀerences between gene sets. We did
not ﬁnd signiﬁcant diﬀerences in predicted NMD fraction,
or the types and locations of PSFs. Based on these
observations, we conclude that pressure to reduce the fre-
quency, or severity of impact of alternative splicing events
is the same for disease genes as non-disease genes.
Stability of protein structures produced by
alternative splicing
For proteins with known or modelable 3D structure we
can ask what fraction of alternative splicing events is likely
to result in a stably folded protein product. For this pur-
pose, possible templates for the major isoform of each
gene were identiﬁed in the PDB, the exons were mapped
on to the 3D structural coordinates, and regions corre-
sponding to PSFs arising from internal deletions were
removed (see ‘Methods’ section). The analysis was per-
formed on the resulting set of modiﬁed protein structures.
The impact of a deletion is measured in terms of the
distance between the resulting chain ends, newly exposed
hydrophobic area, total newly exposed area and number
of residue–residue contacts lost. An example of mapping
of alternative splicing to structural fragments in growth
hormone 1 gene (GH1) is illustrated in Figure 6.
There are no tools for accurate prediction of protein
stability. However, deletion of a randomly chosen exon
is very unlikely to result in a stable protein structure.
We make use of this feature to generate a reference set
of unstable structures, and compare properties of proteins
produced by observed alternative splicing deletions with
these. About 60% of all possible internal exon deletions
result in a frame shift, and almost all of these are predicted
to be degraded by NMD, thus they were not considered in
our calculations.
The remaining 40% of in-frame deletions form a pool
from which the reference set were selected. For each
observed exon deletion included in the analysis, a
random exon deletion with the same number of residues
was found, generating a reference set with the same length
distribution as the observed data. Just as with real dele-
tions, random exon deletions were mapped to 3D struc-
ture coordinates, and regions of chain corresponding to
the exon was removed. The ﬁnal data sets consist of 1439
random deletions and 1439 real deletions (1085 splicing
events observed only in human, 263 in two species, 76 in
three species and 15 in four or more species).
The distributions of various structural features are
shown in Figure 7. The random and full human-only
sets have very similar distributions for all structural prop-
erties. We conclude from this that the large majority of
alternatively spliced deletions, on the one hand, result in
the production of unstable protein folds. On the other
hand, it is immediately obvious that deletions that are
conserved across multiple species tend to remove fewer
residues, have a smaller end-to-end distance, lose fewer
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Figure 5. Fraction of genes with alternative splicing in disease-asso-
ciated genes. All genes (19743 genes, 85136 isoforms), and three subsets
of disease-related genes derived from OMIM (2241 genes), Genetests
(1000 genes) and HGMD (834 genes). The Core set are genes present in
all three databases (530 genes). All sets show a similar distribution of
number of isoforms per gene, with the exception of the ﬁrst set of bars,
which represents the fraction of genes without alternative splicing (7%
vs  2–3% in disease subsets).
4868 Nucleic Acids Research, 2009, Vol. 37,No. 14contacts and expose less total and hydrophobic surface
area. That is, conserved deletions also tend to be conser-
vative in term of structural impact, supporting the view
that these sets are enriched for function compared with
unconserved events.
DISCUSSION
Alternative splicing can generate a large number of iso-
forms starting from a single premessage mRNA. A well-
known example of production of molecular diversity by
alternative splicing is the Drosophila Dscam gene, which
can potentially generate as many as 38000 isoforms (46).
In human, most genes are alternatively spliced (47). Most
(>70%) isoforms change protein coding regions, and
therefore potentially produce novel protein products
(25). On this basis, it is frequently argued that alternative
splicing provides a mechanism for complex organisms
such as human to generate a large number of novel
molecular components from a relatively small number of
genes (6).
The basic assumption in this view is that products of
alternative splicing are functional. However, little is
known about the protein sequences and resulting protein
structure of alternative isoforms. In an eﬀort to decipher
the functionality of isoforms by other means, numerous
bioinformatics studies have analyzed various properties.
It has been found that a small fraction of alternative spli-
cing shows clear signs of functionality, particularly those
exhibiting tissue speciﬁcity (48), expression in high abun-
dance (49) and cross-species conservation (50). Conserved
isoforms especially tend to preserve protein coding frames
and are less likely to be subject to NMD (24,51,52).
Compared to the large body of literature on the eﬀects
of alternative splicing at the message sequence level, rela-
tively little is known about its aﬀect on protein structure
and function.
There have been a few studies regarding the impact of
alternative splicing on tertiary structure of proteins.
Detailed analysis of structural characteristics of alterna-
tive isoforms from ENCODE project by Tress et al. (26) is
largely in agreement with our conclusions—the vast
majority of isoforms show little indication of being
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Figure 6. Alternative splicing in GH1. The exon structure of the major isoform and six minor isoforms are shown as yellow bars. The location of
deletions and truncations in the protein structure relative to the major isoform are highlighted in red. Isoforms A, B, C and D are classiﬁed as
Internal Deletions. Isoforms E and F produce a frame shift and are classiﬁed as C-terminal Truncations. Isoform B was derived from EST sequence,
and part of the exon structure (colored brown) was copied from the major isoform. The isoforms are sorted by severity of impact on structure.
Nucleic Acids Research, 2009,Vol.37, No. 14 4869functional and stable. Homma et al. have analyzed the
location of alternative splice sites and relation to SCOP
domain boundaries. They also found that variants encod-
ing unstable protein products tend to be species speciﬁc
and are expressed at a signiﬁcantly lower levels compared
to stable variants (53). Wang et al. examined 3D models
of alternative isoforms via threading and molecular
dynamics, and concluded that at least in some cases iso-
forms are capable of producing proteins with stable con-
formations (28).
It is clear that the impact of alternative splicing on
protein structure, stability and function remains poorly
understood. Although there seems to be a general
agreement that alternative splicing events conserved
across species probably result in stable and functional pro-
tein products, there seems to be no consensus for species–
speciﬁc isoforms. In other work we argue that a large
fraction of isoforms are products of occasional splicing
mistakes in selection of splice sites (29). That hypothesis
is supported by observations that the increase in number
of isoforms increases with expression level and number of
introns in a gene; that most isoforms are expressed at low
abundance levels and that few show clear tissue speciﬁcity
(54,55). The main principle of the noise hypothesis is that
large error rates can be tolerated as long as adequate levels
of functional products are produced and toxic eﬀects on
Figure 7. Comparison between random exon deletions and deletions observed in minor isoforms. Genes are divided into ﬁve sets: Random Exon
Deletions, Human Only Deletions, Conserved across two, three and four or more species. (A) Number of residues deleted (amino acids). (B) Number
of contacts lost. (C) Newly exposed surface area (A ˚ 2). (D) Newly exposed hydrophobic surface area (A ˚ 2). (E) Distance between Ca atoms at the ends
of a deletion (A ˚ ). (F) Number of EST sequences that support the alternative splicing. For all the structural properties, the random and all human
distributions are very similar, whereas minor isoforms found in multiple species exhibit more conservative structural changes.
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there will be no further selection pressure to reduce the
frequency of alternative splicing, and a great diversity of
isoforms can be generated. A prediction of this model is
that most non-conserved isoforms will be non-functional,
and therefore will tend to disrupt the implied proteins
structure in a random manner.
At the sequence level, we ﬁnd that many alternative
isoforms are predicted to produce proteins that are signif-
icantly smaller than the corresponding major isoforms.
Removing isoforms that are predicted to be subject to
NMD does not change this outcome. These ﬁndings are
in a qualitative agreement with other studies regarding the
impact of alternative splicing on protein sequences (28).
Wang et al. have analyzed alternative isoforms annotated
in the SWISS-PROT database and found that deletions
account for 57% of all annotated events, while insertions
account for only 5% of all annotated splicing events.
Using conservation as a proxy for functionality, we ﬁnd
that small changes in sequence length are more likely to be
conserved. Replacements that do not change the protein
length show the strongest conservation signal. These
observations make sense, since the smaller the change,
the less likely it is to be disruptive to protein structure,
increasing the likelihood of maintaining function or pos-
sibly generating new function. At the level of 3D structure,
we compared the impact of in-frame deletions introduced
by alternative splicing to that of randomly selected
in-frame exon deletions. Random deletions are unlikely
to result in a stable protein fold, and so provide a refer-
ence set for testing the viability of deletions observed in
real isoforms. We ﬁnd that isoforms observed only in
human show the same distribution as the random ones,
for all structural parameters. Deletions that are conserved
across multiple species tend to be more structurally con-
servative—the distances between ends of deletions tend to
be smaller, they expose less hydrophobic surface and lose
fewer contacts. From this observation, we conclude that
most species-speciﬁc isoforms are unlikely to result in
stable conformations.
Our analysis of disease genes did not reveal any surpris-
ing results. If alternative splicing had a negative impact on
the normal functions of these genes, we should have
observed strong selection pleasure to reduce the frequency
and severity of such events, since in this set protein func-
tion is tightly coupled to ﬁtness. No such pressure was
observed. The distributions of number of alternative iso-
forms, fractional abundance of alternative transcripts,
number of NMD isoforms and protein length changes in
disease genes were nearly identical to those for all genes. If
any pressure exists to reduce frequency of alternative splic-
ing, it is not particularly pronounced in this set of genes.
The evidence presented in this study strongly suggests
that the majority of alternative isoforms do not code for
functional protein products and have little impact on phe-
notype, yet they are common, with nearly every gene pro-
ducing several alternatives. These trends are consistent
with noise in the splicing process due to stochastic ﬂuctua-
tions of various splicing factors. Noise is an inherit part of
any complex biological process, and selection forces will
have optimized the ﬁdelity of the splicing system so as to
produce suﬃcient levels of the functional components and
to reduce harmful eﬀects from non-functional products.
Evidently these requirements are satisﬁed at a signiﬁcant
level of noise. An accidental positive aspect of the high
level of noise is that it provides an additional pool of vari-
ability in which novel functional forms can be discovered.
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